ART4 and viral infectious disease: The gp350 subunit vaccination strategy follows the approach successfully used in other viral infections, that is, induction of neutralizing antibodies (nAbs) against the most abundant glycoprotein on the virus, which also represents the main target of naturally occurring nAbs [16].